Back
ESC Professional Premium Access

Worldwide comparative efficacy of nutraceuticals on lipid profile. an updated systematic review and network meta-analysis

Session: Lipids - Drug therapy 1
Topic: Drug therapy
Speaker: Associate Professor T. Osadnik (Zabrze, PL)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Associate Professor Tadeusz Osadnik

Medical University of Silesia in Katowice, Zabrze (Poland)
0 follower

5 more presentations in this session

Correlation of lipoprotein (a) with parameters of lipid profile and other cardiovascular risk factors in patients with familial combined hyperlipidemia

Speaker: Doctor I. Andrikou (Athens, GR)

Access
Abstract
Slides
Like
Thumbnail

Cost-effectiveness of cholesterol-lowering drugs for secondary cardiovascular prevention in the UK: ezetimibe, evolocumab, and alirocumab

Speaker: Doctor T. Michaeli (Mannheim, DE) Doctor D. Michaeli (Mannheim, DE)

Access
Abstract
Slides
Like
Thumbnail

Recurrent atherosclerotic cardiovascular disease events preventable with guideline recommended lipid-lowering treatment following myocardial infarction

Speaker: Doctor R. Rosenson (New York, US)

Access
Abstract
Slides
Like
Thumbnail

Simulation of bempedoic acid in the lipid-lowering treatment pathway using the European contemporary SANTORINI cohort of high- and very high-risk patients

Speaker: Doctor A. Bilitou (Munich, DE)

Access
Abstract
Slides
Like
Thumbnail

PCSK9 inhibitors: effectiveness of treatment and changes in background lipid-lowering therapy in a real world Italian population. The AT-TARGET-IT study

Speaker: Doctor C. Basile (Naples, IT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Lipids - Drug therapy 1

Speakers: Associate Professor T. Osadnik, Doctor I. Andrikou, Doctor T. Michaeli, Doctor D. Michaeli, Doctor R. Rosenson...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources